Christopher T. Groetsch

Internal Medicine
1200 S Cedar Crest Blvd
Allentown, PA 18103

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial.

Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial.

Journal: Cancer cell
Published: June 13, 2024
Showing 1-1 of 1

Last Updated: 09/26/2026